Tag Archives: Serum amyloid A1 (SAA1)

Serum Amyloid A1 as a Potential Intracranial and Extracranial Clinical Severity Biomarker in Traumatic Brain Injury

Cristina Sánchez Carabias et al. Serum Amyloid A1 as a Potential Intracranial and Extracranial Clinical Severity Biomarker in Traumatic Brain Injury. Journal of Intensive Care Medicine. Publication Date April 8, 2019 How Analyze was Used “Biomarkers were quantified by enzyme-linked immunosorbent assay. Intracranial lesion volume was measured from the semiautomatic segmentation of hematoma on computed…